Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report

• मुख्य लेखकों: Baldwin Kaitlyn PharmD (लेखक), Wanson Annabelle MD, FRCPC (लेखक), Gilecki Lee-Anne MD, FRCPC (लेखक), Dalton Courtney BSP (लेखक), Peters Evyn MD, FRCPC (लेखक), Halpape Katelyn BSP, ACPR, PharmD, BCPP (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: American Association of Psychiatric Pharmacists, 2023-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limited efficacy in the presence of inflammation. Although ketamine has shown promis...